Skip to content
Disclosery

BRAIDWELL LP

Follow

13F filer, CIK 1920938, STAMFORD, CT

BRAIDWELL LP reported holdings worth $3,372,652,431 (the sum of its rows) across 73 holdings for the quarter ended 2024-12-31, in a 13F-HR filed 2025-02-14. The total stated on the cover page is $3,862,183,431. Its ten largest share positions make up 37.46% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001920938-25-000002

The cover page states a total of $3,862,183,431, 15% more than the sum of the rows, $3,372,652,431. This page uses the sum of the rows.

Period
2024-12-31
Value, sum of rows
$3.37B
Stated on the cover page
$3.86B
Holdings
73
Top 10 weight
37.46%
New
14
Sold out
22

Largest buys vs the previous quarter

SecurityShares changeApprox. value
TMDXnew+922,100$57.5M
LEGNadded+1,436,400$46.7M
TMOnew+89,754$46.7M
GERNnew+7,006,315$24.8M
BRKRnew+353,200$20.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
PENreduced-177,600-$42.2M
MDGLexited-183,818-$39M
APLSreduced-1,026,317-$32.7M
ARVNexited-1,284,472-$31.6M
DXCMexited-441,086-$29.6M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2024

Share positions as resolved from 13F-HR 0001920938-25-000002, largest first. % of portfolio is the value over $3,372,652,431, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 917,674 shares; 2024Q4: 901,790 shares 901,790$123M3.65%-15,884Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,707,255 shares; 2024Q4: 2,913,964 shares 2,913,964$114M3.39%+206,709Timeline
LEGNLEGEND BIOTECH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,541,551 shares; 2024Q4: 2,977,951 shares 2,977,951$96.9M2.87%+1,436,400Timeline
CGONCG ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,170,875 shares; 2024Q4: 3,283,317 shares 3,283,317$94.2M2.79%+112,442Timeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,342,124 shares; 2024Q4: 2,847,931 shares 2,847,931$87M2.58%-494,193Timeline
ALGNALIGN TECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 311,679 shares; 2024Q4: 375,179 shares 375,179$78.2M2.32%+63,500Timeline
APGEAPOGEE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,643,226 shares; 2024Q4: 1,540,362 shares 1,540,362$69.8M2.07%-102,864Timeline
KNSAKINIKSA PHARMACEUTICALS INTLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,894,513 shares; 2024Q4: 3,452,447 shares 3,452,447$68.3M2.02%+557,934Timeline
APLSAPELLIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,125,183 shares; 2024Q4: 2,098,866 shares 2,098,866$67M1.99%-1,026,317Timeline
IRTCIRHYTHM HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 782,557 shares; 2024Q4: 705,391 shares 705,391$63.6M1.89%-77,166Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,958,310 shares; 2024Q4: 2,332,196 shares 2,332,196$62.3M1.85%+373,886Timeline
DAWNDAY ONE BIOPHARMACEUTICALS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,873,853 shares; 2024Q4: 4,873,853 shares 4,873,853$61.8M1.83%0Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,189,836 shares; 2024Q4: 2,578,404 shares 2,578,404$60M1.78%+388,568Timeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,156,977 shares; 2024Q4: 1,479,666 shares 1,479,666$59.5M1.77%+322,689Timeline
TMDXTRANSMEDICS GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 922,100 shares 922,100$57.5M1.7%newTimeline
INSPINSPIRE MED SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 238,911 shares; 2024Q4: 293,410 shares 293,410$54.4M1.61%+54,499Timeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 96,724 shares; 2024Q4: 80,766 shares 80,766$49.7M1.47%-15,958Timeline
TMOTHERMO FISHER SCIENTIFIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 89,754 shares 89,754$46.7M1.38%newTimeline
MRVIMARAVAI LIFESCIENCES HLDGS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 8,353,287 shares; 2024Q4: 8,353,287 shares 8,353,287$45.5M1.35%0Timeline
SRPTSAREPTA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 370,400 shares; 2024Q4: 364,900 shares 364,900$44.4M1.32%-5,500Timeline
PENPENUMBRA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 361,428 shares; 2024Q4: 183,828 shares 183,828$43.7M1.29%-177,600Timeline
GKOSGLAUKOS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 311,616 shares; 2024Q4: 288,876 shares 288,876$43.3M1.28%-22,740Timeline
AVADEL PHARMACEUTICALSAVADEL PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,388,939 shares; 2024Q4: 4,105,726 shares 4,105,726$43.2M1.28%+716,787
RGENREPLIGEN CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 396,781 shares; 2024Q4: 283,823 shares 283,823$40.9M1.21%-112,958Timeline
PARAGON 28 INCPARAGON 28 INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,135,109 shares; 2024Q4: 3,834,809 shares 3,834,809$39.6M1.17%-300,300
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 91,300 shares; 2024Q4: 75,300 shares 75,300$39.3M1.17%-16,000Timeline
ATECALPHATEC HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,041,065 shares; 2024Q4: 4,256,490 shares 4,256,490$39.1M1.16%+215,425Timeline
BNTXBIONTECH SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 247,750 shares; 2024Q4: 309,865 shares 309,865$35.3M1.05%+62,115Timeline
BCAXBICARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,657,600 shares; 2024Q4: 2,000,659 shares 2,000,659$34.9M1.03%+343,059Timeline
KRYSKRYSTAL BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 168,691 shares; 2024Q4: 200,500 shares 200,500$31.4M0.93%+31,809Timeline
HROWHARROW INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 439,638 shares; 2024Q4: 907,039 shares 907,039$30.4M0.9%+467,401Timeline
KROSKEROS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 707,240 shares; 2024Q4: 1,894,439 shares 1,894,439$30M0.89%+1,187,199Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 515,726 shares; 2024Q4: 1,147,676 shares 1,147,676$27.1M0.8%+631,950Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 493,687 shares; 2024Q4: 1,206,589 shares 1,206,589$26.3M0.78%+712,902Timeline
KIDSORTHOPEDIATRICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,107,770 shares; 2024Q4: 1,107,770 shares 1,107,770$25.7M0.76%0Timeline
IMTXIMMATICS N.VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,647,565 shares; 2024Q4: 3,503,965 shares 3,503,965$24.9M0.74%+1,856,400Timeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 7,006,315 shares 7,006,315$24.8M0.74%newTimeline
IRWDIRONWOOD PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,438,232 shares; 2024Q4: 5,440,277 shares 5,440,277$24.1M0.71%+1,002,045Timeline
BRKRBRUKER CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 353,200 shares 353,200$20.7M0.61%newTimeline
EXASEXACT SCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 286,178 shares; 2024Q4: 353,000 shares 353,000$19.8M0.59%+66,822Timeline
NUVLNUVALENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 241,235 shares 241,235$18.9M0.56%newTimeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 297,568 shares; 2024Q4: 222,424 shares 222,424$18.2M0.54%-75,144Timeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,070,837 shares; 2024Q4: 1,477,102 shares 1,477,102$17.9M0.53%-1,593,735Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 681,182 shares 681,182$16M0.48%newTimeline
JSPRJASPER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 483,300 shares; 2024Q4: 714,658 shares 714,658$15.3M0.45%+231,358Timeline
CGEMCULLINAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,176,173 shares; 2024Q4: 1,176,173 shares 1,176,173$14.3M0.42%0Timeline
XNCRXENCOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 466,448 shares; 2024Q4: 615,531 shares 615,531$14.1M0.42%+149,083Timeline
CADLCANDEL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 1,600,000 shares 1,600,000$13.9M0.41%newTimeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 802,100 shares 802,100$11.9M0.35%newTimeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 884,306 shares; 2024Q4: 884,306 shares 884,306$11.6M0.34%0Timeline
FDMT4D MOLECULAR THERAPEUTICS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,225,448 shares; 2024Q4: 1,225,448 shares 1,225,448$6.83M0.2%0Timeline
NEVRO CORPNEVRO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,698,768 shares; 2024Q4: 1,698,768 shares 1,698,768$6.32M0.19%0
ZURAZURA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,472,806 shares; 2024Q4: 2,472,806 shares 2,472,806$6.18M0.18%0Timeline
CBLLCERIBELL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 210,000 shares 210,000$5.43M0.16%newTimeline
LUNGPULMONX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 752,541 shares; 2024Q4: 752,541 shares 752,541$5.11M0.15%0Timeline
AEROVATE THERAPEUTICS INCAEROVATE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 1,440,499 shares 1,440,499$3.82M0.11%new
SKYESKYE BIOSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 825,732 shares 825,732$2.34M0.07%newTimeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 20,109 shares 20,109$776K0.02%newTimeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 34,094 shares 34,094$654K0.02%newTimeline

Principal amounts

Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).

SecurityTypeAmountValueChange
GUARDANT HEALTH INCGUARDANT HEALTH INC NOTE 11/1principal268,252,000$226M0
BRIDGEBIO PHARMA INCBRIDGEBIO PHARMA INC NOTE 2.500% 3/1principal140,838,000$148M0
NOVOCURE LTDNOVOCURE LTD NOTE 11/0principal140,834,000$134M0
REPLIGEN CORPREPLIGEN CORP NOTE 1.000%12/1principal112,000,000$115Mnew
NUVASIVE INCNUVASIVE INC NOTE 0.375% 3/1principal114,206,000$113M0
NEOGENOMICS INCNEOGENOMICS INC NOTE 0.250% 1/1principal116,381,000$98.3M0
IRONWOOD PHARMACEUTICALS INCIRONWOOD PHARMACEUTICALS INC NOTE 1.500% 6/1principal92,740,000$85.2M0
DEXCOM INCDEXCOM INC NOTE 0.375% 5/1principal82,700,000$74.4M-10,000,000
ALPHATEC HLDGS INCALPHATEC HLDGS INC NOTE 0.750% 8/0principal58,217,000$55.1M0
BRIDGEBIO PHARMA INCBRIDGEBIO PHARMA INC Convertibleprincipal53,594,000$46M0
DEXCOM INCDEXCOM INC NOTE 0.250%11/1principal18,500,000$17.9M-55,000,000
AMPHASTAR PHARMACEUTICALS INAMPHASTAR PHARMACEUTICALS IN NOTE 2.000% 3/1principal17,400,000$16.3M-1,000,000
CUTERA INCCUTERA INC NOTE 4.000% 6/0principal29,000,000$2.61M0
CUTERA INCCUTERA INC NOTE 2.250% 6/0principal25,240,000$2.27M0

Sold out in Q4 2024

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
INSULET CORPINSULET CORP63,800,000$76.4Mprincipal
TRAVERE THERAPEUTICS INCTRAVERE THERAPEUTICS INC56,031,000$53.5Mprincipal
MDGLMADRIGAL PHARMACEUTICALS INC183,818$39Mshares
ARVNARVINAS INC1,284,472$31.6Mshares
DXCMDEXCOM INC441,086$29.6Mshares
RLAYRELAY THERAPEUTICS INC3,499,427$24.8Mshares
OCULOCULAR THERAPEUTIX INC2,239,770$19.5Mshares
BSXBOSTON SCIENTIFIC CORP189,200$15.9Mshares
HAEMONETICS CORP MASSHAEMONETICS CORP MASS11,500,000$10.6Mprincipal
ALECALECTOR INC2,158,245$10.1Mshares
PODDINSULET CORP42,500$9.89Mshares
CSTLCASTLE BIOSCIENCES INC331,986$9.47Mshares
BBIOBRIDGEBIO PHARMA INC298,400$7.6Mshares
LXEOLEXEO THERAPEUTICS INC728,777$6.59Mshares
SKINSKINHEALTH SYSTEMS INC4,049,694$5.83Mshares
FULCFULCRUM THERAPEUTICS INC1,069,158$3.82Mshares
VERVE THERAPEUTICS INCVERVE THERAPEUTICS INC623,980$3.02Mshares
IOVAIOVANCE BIOTHERAPEUTICS INC217,928$2.05Mshares
HILLEVAX INCHILLEVAX INC1,064,000$1.87Mshares
LXRXLEXICON PHARMACEUTICALS INC801,584$1.26Mshares
DBV TECHNOLOGIES S ADBV TECHNOLOGIES S A1,630,542$1.14Mshares
ELEVATION ONCOLOGY INC COMELEVATION ONCOLOGY INC COM473,503$284Kshares

How Q4 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001920938-25-000002 base2025-02-14acceptance time not in the bulk data set